Biomarkers are emerging as potential alternative tools for TB diagnosis, prediction of disease progression, and evaluation of treatment efficacy [9], such as interferon-γ (IFN-γ) release assay (IGRA) for identification of latent tuberculosis infection (LTBI). The gene discussed is IFNG; the disease is tuberculosis.